Takeda Selects Two New Partners for Annual Global Corporate Social Responsibility (CSR) Program to Support Strong Health Systems and Access to Healthcare in Developing Countries
Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) today announced the addition of two partners to its Global Corporate Social Responsibility (CSR) Program, which makes long-term commitments to strengthen healthcare systems and improve access to healthcare for all in developing countries. As part of an annual decision-making process, Takeda employees worldwide have voted to add the Access to Health Fund and Bridges to Development as new partners for the Global CSR Program, which now supports 16 programs in more than 60 countries.
Takeda’s commitments to these new partner organizations in FY2020 include:
- JPY 1.1 billion (USD 10.1 million*) to Access to Health Fund to help build and improve community health centers and empower health staff from ethnic health organizations and ethnic community-based health organizations (EHOs/ECBHOs) in Myanmar’s Shan State to deliver quality health services, particularly for mothers and children, over the next 5 years.
- JPY 681 million (USD 6.3 million*) to Bridges to Development to eliminate or control 5 neglected tropical diseases in Papua New Guinea and Vanuatu including lymphatic filariasis, yaws, leprosy, trachoma, and soil-transmitted helminthiases. The 3-year project will improve health worker capacity, access to care and treatment.
“We welcome and very much value the interest that Takeda and its employees have shown in contributing to improving the health of vulnerable populations in conflict-affected and hard-to-reach areas in Shan State in Myanmar,” said Oren Ginzburg, Access to Health Fund Director.
“The Bridges team is thrilled to embark on this important work in service of communities and populations that have been frequently left behind,” said Julie Jacobson, Managing Partner & Co-Founder of Bridges to Development. “In this project, working with countries, we aim to achieve lasting health benefits through the elimination and control of several neglected tropical diseases in one innovative approach. We are thankful to Takeda employees who helped make this possible with their support.”
This year represents the 5th anniversary of Takeda’s Global CSR Program, which empowers employees in Takeda’s 80 countries of operation to be the decisionmakers for which innovative, high-impact activities receive the Company’s support. The Program, rooted in the company’s values, actively partners with world-class organizations and nongovernmental organizations (NGOs) with proven track records of addressing global health problems in effective, enduring ways to prevent disease, train health workers, strengthen supply chains, and improve access to quality diagnosis and treatment for patients worldwide.
“Since its launch in 2016, Takeda’s Global CSR Program has focused on initiatives that strengthen health systems and increase access across the patient journey in low- and middle-income countries. We’re expecting to reach at least 17 million beneficiaries through 2025 globally” said Takako Ohyabu, Chief Global Corporate Affairs Officer. “We are proud to partner with the Access to Health Fund and Bridges to Development as we strive to increase health worker capacity and preventive care for patients everywhere, ensure reliable access to essential equipment and supplies, and empower communities with knowledge, services, and access to care."
In less than five years, Takeda’s Global CSR Program partners have delivered transformational impact that serves communities worldwide today and will continue to contribute to better health outcomes and stronger health systems for years to come, including:
- JOICFP, Plan International, and UNICEF reached nearly 700,000 pregnant women and mothers, newborns, children, and adolescents, with quality health care, services, and education in sub-Saharan Africa and the Middle East.
- JOICFP, Plan International, Seed Global Health, and UNICEF in Africa and the Middle East, with World Vision in South Asia, have collectively trained approximately 6,000 health workers in 15 countries, including qualified nurses, midwives, and physician trainees, as well as community health workers and nutrition volunteers.
- Millions of children have been immunized against measles, and the capacity of trainings offered by academic and clinical institutions in sub-Saharan Africa has been expanded exponentially.
In line with Takeda’s core values and longstanding support for strong health systems and access to healthcare for all, Takeda recently announced contributions to the global COVID-19 response through three United Nations-led organizations to strengthen health systems, improve access to care and supplies, and address food insecurity.
Takeda also forges farsighted public-private philanthropic partnerships with game-changing multilateral and academic institutions worldwide, such as with The Global Fund to Fight AIDS, Tuberculosis and Malaria, and the London School of Hygiene & Tropical Medicine.
* Financial information relating to the donations has been converted from JPY to USD using the ¥108.87:$1 as of June 3, 2020. For the avoidance of doubt, the amounts payable as part of the donations are denominated in JPY.
Takeda Pharmaceutical Company Limited
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Shionogi Announces Publication of a New Systematic Review in CHEST Highlighting the Importance of Early, Appropriate Therapy to Improve Meaningful Outcomes Like Mortality in Patients With Severe Bacterial Infections1.10.2020 15:14:00 CEST | Press release
Shionogi B.V., the European subsidiary of Shionogi & Co., Ltd. (Head Office: Osaka, Japan; President & CEO: Isao Teshirogi, Ph.D.; hereafter "Shionogi") today announce the publication of a new systematic review in CHEST Journal, funded by Shionogi B.V, examining the effect of delayed appropriate antibiotic therapy on the outcomes of patients with severe bacterial infections.1 The review was carried out to characterise the impact of time to effective therapy for antimicrobials and guide treatment decisions to optimise prompt appropriate antibiotic therapy for patients most at risk. The study found that mortality was significantly lower in patients receiving appropriate therapy without delay compared with those experiencing delay.1 Severe bacterial infections requiring in-hospital treatment are associated with considerable mortality, morbidity and healthcare costs. Physicians must often initiate antibiotic therapy before the pathogen causing the infection and its drug-resistance profile
PTR Robots Introduces World’s First Mobile Lifting Robot That Both Transfers and Rehabilitates Patients1.10.2020 15:02:00 CEST | Press release
PTR Robots, a Danish service-robot company, announced the world premiere of its robot that can mobilize and transfer patients. Jointly developed with healthcare professionals, the PTR Robot is the first mobile, intelligent robot solution that can flexibly move around in the healthcare and nursing sectors. While it helps individuals with impaired functions to be transferred and rehabilitated, it also relieves the strain on staff, redirecting them from labor-intensive tasks. A PTR Robot also reduces the risk of infection, because only one caregiver needs to be present to perform a patient transfer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201001005084/en/ PTR Robots was developed and tested in close collaboration with Zealand University Hospital, and Vonsildhave Nursing Home, operated by the nursing group Attendo. “The testing of PTR Robots really impressed us. We can see interesting perspectives in the way we can assist
Fastly Completes Acquisition of Signal Sciences1.10.2020 15:00:00 CEST | Press release
Fastly, Inc. (NYSE: FSLY), provider of an edge cloud platform, today announced it has successfully completed the acquisition of Signal Sciences (“Signal Sciences”). The transaction combines Signal Sciences’ powerful web application and API security solutions with Fastly’s edge cloud platform and existing security offerings to form a unified suite of modern security tools. This robust new security portfolio, designed for the way developers work, unlocks innovation at the edge and removes silos between developers, operations, and security teams to shorten development cycles and protect websites and web applications alike. “We are excited to close this transaction and welcome the talented team at Signal Sciences to Fastly,” said Joshua Bixby, Chief Executive Officer of Fastly. “Our companies are similarly focused on giving developers more control and visibility by designing offerings that embrace modern DevOps practices. Together with Signal Sciences, we will deliver a web application and
Rimini Street Appoints Michael L. Perica as CFO1.10.2020 15:00:00 CEST | Press release
Rimini Street, Inc. (Nasdaq: RMNI), a global provider of business software products and services, the leading third-party support provider for Oracle and SAP software products and a Salesforce partner, today announced the appointment of Michael L. Perica as executive vice president and chief financial officer (CFO) to support the Company’s next phase of growth. Perica leads the finance strategy and execution for Rimini Street and its global subsidiaries, and is responsible for all financial operations of the Company including global financial planning and analysis, accounting, revenue management, global treasury and tax, SEC reporting, finance systems and processes, audit, capital structure, capital markets activities, M&A and investor relations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201001005035/en/ Rimini Street Appoints Michael L. Perica as CFO (Photo: Business Wire) Successful 25 Year Track-Record in Financial M
Bacardi Limited Welcomes Beverage Industry Veteran Todd Grice as General Counsel1.10.2020 14:15:00 CEST | Press release
Bacardi Limited, the world’s largest privately held spirits company, today announces the appointment of Todd Grice as Senior Vice President and General Counsel. Grice brings 25 years of legal practice to Bacardi, including the last 18 with The Coca-Cola Company, with extensive business and legal expertise in corporate governance, competition law, securities law, intellectual property, mergers and acquisitions, and commercial transactions. This appointment follows the long-planned retirement of Eduardo Sanchez who served as the company’s SVP and General Counsel for 17 years. Grice will report to Chief Executive Officer Mahesh Madhavan and joins the company’s Global Leadership Team. At Bacardi, Grice will be responsible for legal and government affairs including legal strategy, governance and compliance, strategic transactions, and dispute resolution and regulatory matters. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201001
ExaGrid Nominated in Seven Categories for the 2020 Storage Awards1.10.2020 14:00:00 CEST | Press release
ExaGrid®, the industry’s only Tiered Backup Storage solution, today announced that it has been nominated in seven categories for the 17th annual Storage Awards. ExaGrid has become a finalist for Contribution to the Storage Industry, Hyper-convergence Vendor of the Year, Enterprise Backup Hardware Company of the Year, Storage Innovators of the Year, Storage Performance Optimisation Company of the Year, Storage Product of the Year, and Storage Company of the Year. Voting to determine the winner in each category is underway now and closes on November 12. Winners of this year’s awards will be announced on November 26, 2020. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201001005189/en/ While ExaGrid has been recognized in five award categories as a company, its product line, the EX Series of Tiered Backup Storage appliances, is also nominated in the Storage Product of the Year category, and this year is especially unique as Exa
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom